P3 Health Partners Inc expected to post a loss of 11 cents a share - Earnings Preview

P3 Health Partners

26/03/2024 21:08

* P3 Health Partners Inc  PIII.OQ   PIII.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 28
for the period ending December 31 2023
    * The Chicago Illinois-based  company is expected to report
a
17.3% increase in revenue to $302.968 million from $258.2
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data. (DECY Quarters may not add to
annual due to changes in shares outstanding)
    * ​LSEG's mean analyst estimate for P3 Health Partners Inc
is for
a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for P3 Health
Partners Inc is $4.25​, above​ its last closing price of $1.02.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.29       -0.22      -0.12     Beat    45.5
 Jun. 30 2023  -0.14       -0.13      -0.09     Beat    30.8
 Mar. 31 2023  -0.63       -0.67      -0.22     Beat    67.4​
 Dec. 31 2022              -0.91      -2.26     Missed  -148.4
 ​​Sep.        -0.47       -0.46      -0.27     Beat    41.7
 30 2022                                                
 Jun. 30 2022              -0.16      -0.21     Missed  -31.2​
 Mar. 31 2022              -0.12      -0.25     Missed  -102.7
 Dec. 31 2021              -0.24      -0.24     Met     1.4
 This summary was machine generated March 26 at 21:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)